CRYAB and neoplasm: Using the mouse embryonic fibroblasts (MEFs) from this mouse model, we show that Cryab overexpression alters multiple signaling pathways, particularly those related to apoptosis, survival, and metastasis which have potential implications for tumor initiation and therapy development.